Check Out Our Latest TSLS The field of dermatology continues to evolve at a rapid pace, bringing groundbreaking research from the lab to the clinic. As part of its ongoing…
Corticosteroids have been the effective, accessible, and familiar backbone of dermatologic therapy for decades. But with great power comes great responsibility. In this episode, podcast host Dr. Adam Friedman, Professor…
Niacinamide still useful — but high oral doses may carry cardiovascular risk A literature review confirms that oral nicotinamide (niacinamide) is a versatile, generally well‑tolerated tool in dermatology: it reduces…
Join Seemal Desai, MD, FAAD, as he presents the latest over-the-counter product innovations from L'Oréal Dermatological Beauty's trusted brands: CeraVe and La Roche-Posay. Dr. Desai will present new clinical and…
Ranked As A Top 10 Dermatology Podcast The JDD podcast, hosted by Dr. Friedman, was recently ranked as a top ten dermatology podcast by Feedspot. We are grateful for the…
Caffeine shows promise for hair loss, but evidence remains preliminary A systematic review identified nine studies—five randomized controlled trials, three prospective cohorts and one twin‑twin cohort—evaluating caffeine interventions for hair…
Breakthroughs in atopic dermatitis are redefining treatment from the inside out. Discover how new data on race, microbes, and patient preferences are transforming the way we think about AD. In…
Barrier boost with benefits - new topical cream raises filaggrin, hyaluronic acid and lipids while improving tolerability A novel topical cream moisturizer produced meaningful biological and clinical improvements in both…
Exosome complex after microneedling shows promising hair‑regrowth signals in a 30‑patient series In a 30‑subject study (15 men, 15 women; mean age 50.2 years) treated with an Exosome Regenerative Complex+…
Think beyond inflammation: SAIGE framing reframes pediatric AD prevention and care A seven‑expert global panel of pediatric dermatologists and dermatologists used a modified Delphi process to produce five consensus statements…
Dupilumab delivers — but many patients need more than monotherapy over time In a US retrospective cohort (OM1 PremiOM™ AD) of 5,200 patients who started dupilumab between 2017-2021 (208 children, 430…
Join Dr. Kachiu Lee, a board-certified cosmetic dermatologist, to learn more about new innovations of SkinCeuticals. Dr. Lee will share the latest integrated skincare science from SkinCeuticals, focusing on products…